Showing results (161-170 of 741) with videos related to

Sort By:
Pageof 75
Mayo Clinic Proceedings|February 7, 2021
Coagulation Abnormalities in Light Chain AmyloidosisNadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Blood Cancer Journal|December 6, 2022
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosisTaxiarchis V Kourelis, Shaji K Kumar, Morie A Gertz, et al.
Mayo Clinic Proceedings|August 14, 2002
Current therapy for multiple myelomaS Vincent Rajkumar, Morie A Gertz, Robert A Kyle, et al.
Archives of Dermatology|October 18, 2006
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myelomaHans P Sviggum, Mark D P Davis, S Vincent Rajkumar, et al.
Cancer|February 19, 2008
Thromboembolic events with lenalidomide-based therapy for multiple myelomaSmitha Patiyil Menon, S Vincent Rajkumar, Martha Lacy, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Dermatologic side effects of thalidomide in patients with multiple myelomaVirginia C Hall, Rokea A El-Azhary, Saskia Bouwhuis, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Pageof 75